Clinical Trial Update: IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for IL-5 CAR-T cell therapy in refractory/relapsed eosinophilic leukemia; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Leukemia

Drugs mentioned

• IL-5 CAR-T Cell Therapy (IL-5 CAR-T)

Snippet

Sponsor: Zhejiang University | Conditions: Hematologic Diseases, Neoplasms | Phase 1 | Status: RECRUITING